204 related articles for article (PubMed ID: 33874885)
21. IL-15 enhances the function and inhibits CD95/Fas-induced apoptosis of human CD4+ and CD8+ effector-memory T cells.
Mueller YM; Makar V; Bojczuk PM; Witek J; Katsikis PD
Int Immunol; 2003 Jan; 15(1):49-58. PubMed ID: 12502725
[TBL] [Abstract][Full Text] [Related]
22. Human vascular endothelial cells stimulate memory but not naive CD8+ T cells to differentiate into CTL retaining an early activation phenotype.
Dengler TJ; Pober JS
J Immunol; 2000 May; 164(10):5146-55. PubMed ID: 10799873
[TBL] [Abstract][Full Text] [Related]
23. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
[TBL] [Abstract][Full Text] [Related]
24. Effects of interleukin-12 on the induction of cytotoxic T lymphocytes from the regional lymph node lymphocytes of patients with lung adenocarcinoma.
Hanagiri T; Yoshino I; Takenoyama M; So T; Fujie H; Imabayashi S; Eifuku R; Yoshimatsu T; Osaki T; Nakanishi R; Ichiyoshi Y; Nagashima A; Nomoto K; Yasumoto K
Jpn J Cancer Res; 1998 Feb; 89(2):192-8. PubMed ID: 9548447
[TBL] [Abstract][Full Text] [Related]
25. Induction of granulysin in CD8+ T cells by IL-21 and IL-15 is suppressed by human immunodeficiency virus-1.
Hogg AE; Bowick GC; Herzog NK; Cloyd MW; Endsley JJ
J Leukoc Biol; 2009 Nov; 86(5):1191-203. PubMed ID: 19687290
[TBL] [Abstract][Full Text] [Related]
26. The differential production of cytokines by human Langerhans cells and dermal CD14(+) DCs controls CTL priming.
Banchereau J; Thompson-Snipes L; Zurawski S; Blanck JP; Cao Y; Clayton S; Gorvel JP; Zurawski G; Klechevsky E
Blood; 2012 Jun; 119(24):5742-9. PubMed ID: 22535664
[TBL] [Abstract][Full Text] [Related]
27. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
28. Functional Alteration of Natural Killer Cells and Cytotoxic T Lymphocytes upon Asbestos Exposure and in Malignant Mesothelioma Patients.
Nishimura Y; Kumagai-Takei N; Matsuzaki H; Lee S; Maeda M; Kishimoto T; Fukuoka K; Nakano T; Otsuki T
Biomed Res Int; 2015; 2015():238431. PubMed ID: 26161391
[TBL] [Abstract][Full Text] [Related]
29. IL-15 induces unspecific effector functions in human peptide-specific CD8+ T-cell cultures.
Lyngstrand ST; Würtzen PA; Ødum N; Nissen MH; Röpke C
Scand J Immunol; 2002 Dec; 56(6):602-10. PubMed ID: 12472672
[TBL] [Abstract][Full Text] [Related]
30. IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype.
Albrecht J; Frey M; Teschner D; Carbol A; Theobald M; Herr W; Distler E
Cancer Immunol Immunother; 2011 Feb; 60(2):235-48. PubMed ID: 21046101
[TBL] [Abstract][Full Text] [Related]
31. IL-15-induced human DC efficiently prime melanoma-specific naive CD8+ T cells to differentiate into CTL.
Dubsky P; Saito H; Leogier M; Dantin C; Connolly JE; Banchereau J; Palucka AK
Eur J Immunol; 2007 Jun; 37(6):1678-90. PubMed ID: 17492620
[TBL] [Abstract][Full Text] [Related]
32. [IL-7/IL-15/IL-21/IL-23 effectively promote the generation of human CD8
Pan C; Li J; Chen S; Yu H; Ye Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Oct; 37(10):872-880. PubMed ID: 34670663
[TBL] [Abstract][Full Text] [Related]
33. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy.
Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH
Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
35. IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).
Ferrari G; King K; Rathbun K; Place CA; Packard MV; Bartlett JA; Bolognesi DP; Weinhold KJ
Clin Exp Immunol; 1995 Aug; 101(2):239-48. PubMed ID: 7544247
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-15 triggers activation and growth of the CD8 T-cell pool in extravascular tissues of patients with acquired immunodeficiency syndrome.
Agostini C; Trentin L; Sancetta R; Facco M; Tassinari C; Cerutti A; Bortolin M; Milani A; Siviero M; Zambello R; Semenzato G
Blood; 1997 Aug; 90(3):1115-23. PubMed ID: 9242543
[TBL] [Abstract][Full Text] [Related]
37. Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte.
Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
Int Immunopharmacol; 2009 Jan; 9(1):97-102. PubMed ID: 18992850
[TBL] [Abstract][Full Text] [Related]
38. IL-15 is a growth factor and an activator of CD8 memory T cells.
Weng NP; Liu K; Catalfamo M; Li Y; Henkart PA
Ann N Y Acad Sci; 2002 Dec; 975():46-56. PubMed ID: 12538153
[TBL] [Abstract][Full Text] [Related]
39. Alloantigen-specific T suppressor-inducer and T suppressor-effector cells can be activated despite blocking the IL-2 receptor.
Tan P; Anasetti C; Martin PJ; Hansen JA
J Immunol; 1990 Jul; 145(2):485-8. PubMed ID: 1973183
[TBL] [Abstract][Full Text] [Related]
40. A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells.
Brignone C; Grygar C; Marcu M; Schäkel K; Triebel F
J Immunol; 2007 Sep; 179(6):4202-11. PubMed ID: 17785860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
